Concepedia

Publication | Open Access

Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study

DOIFull Paper Access

81

Citations

15

References

2015

Year

Chukiat Sirivichayakul, Elizabeth A Barranco-Santana, Inés Esquilin-Rivera, Helen Oh, Marsha G. Raanan, Carlos A. Sariol, Lynette Pei‐Chi Shek, Sriluck Simasathien, Mary Smith, Iván Darío Vélez,
The Journal of Infectious Diseases

Abstract

TDV was well tolerated and immunogenic in volunteers aged 1.5-45 years, irrespective of prevaccination dengue exposure.

References

YearCitations

Page 1